PortfoliosLab logoPortfoliosLab logo
PCRB vs. IBCA
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PCRB vs. IBCA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Putnam ESG Core Bond ETF - (PCRB) and iShares iBonds Dec 2035 Term Corporate ETF (IBCA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PCRB achieves a -0.32% return, which is significantly lower than IBCA's 0.20% return.


PCRB

1D
-0.13%
1M
-0.22%
YTD
-0.32%
6M
-0.43%
1Y
4.53%
3Y*
4.09%
5Y*
10Y*

IBCA

1D
-0.27%
1M
0.37%
YTD
0.20%
6M
0.04%
1Y
6.55%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PCRB vs. IBCA - Yearly Performance Comparison


Correlation

The correlation between PCRB and IBCA is 0.90, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.90

Correlation (All Time)
Calculated using the full available price history since Mar 27, 2025

0.87

The correlation between PCRB and IBCA has been stable across timeframes, ranging from 0.87 to 0.90 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PCRB vs. IBCA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PCRB
PCRB Risk / Return Rank: 3333
Overall Rank
PCRB Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
PCRB Sortino Ratio Rank: 3535
Sortino Ratio Rank
PCRB Omega Ratio Rank: 3131
Omega Ratio Rank
PCRB Calmar Ratio Rank: 3131
Calmar Ratio Rank
PCRB Martin Ratio Rank: 3333
Martin Ratio Rank

IBCA
IBCA Risk / Return Rank: 3939
Overall Rank
IBCA Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
IBCA Sortino Ratio Rank: 3939
Sortino Ratio Rank
IBCA Omega Ratio Rank: 3636
Omega Ratio Rank
IBCA Calmar Ratio Rank: 4343
Calmar Ratio Rank
IBCA Martin Ratio Rank: 4242
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PCRB vs. IBCA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Putnam ESG Core Bond ETF - (PCRB) and iShares iBonds Dec 2035 Term Corporate ETF (IBCA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PCRBIBCADifference
Sharpe ratioReturn per unit of total volatility

-0.12

Sortino ratioReturn per unit of downside risk

-0.13

Omega ratioGain probability vs. loss probability

1.21

1.23

-0.02

Calmar ratioReturn relative to maximum drawdown

1.51

2.07

-0.56

Martin ratioReturn relative to average drawdown

4.90

6.57

-1.66

PCRB vs. IBCA - Sharpe Ratio Comparison

The current PCRB Sharpe Ratio is 1.21, which is comparable to the IBCA Sharpe Ratio of 1.33. The chart below compares the historical Sharpe Ratios of PCRB and IBCA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PCRBIBCADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.21

1.33

-0.12

Sharpe Ratio (All Time)

Calculated using the full available price history

0.59

1.08

-0.49

Drawdowns

PCRB vs. IBCA - Drawdown Comparison

The maximum PCRB drawdown since its inception was -7.20%, which is greater than IBCA's maximum drawdown of -3.48%. Use the drawdown chart below to compare losses from any high point for PCRB and IBCA.


Loading charts...

Drawdown Indicators


PCRBIBCADifference

Max Drawdown

Largest peak-to-trough decline

-7.20%

-3.48%

-3.72%

Max Drawdown (1Y)

Largest decline over 1 year

-3.02%

-3.19%

+0.17%

Max Drawdown (3Y)

Largest decline over 3 years

-5.85%

Current Drawdown

Current decline from peak

-2.18%

-1.42%

-0.76%

Average Drawdown

Average peak-to-trough decline

-1.64%

-0.81%

-0.83%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.93%

1.00%

-0.07%

Volatility

PCRB vs. IBCA - Volatility Comparison

The current volatility for Putnam ESG Core Bond ETF - (PCRB) is 1.32%, while iShares iBonds Dec 2035 Term Corporate ETF (IBCA) has a volatility of 1.62%. This indicates that PCRB experiences smaller price fluctuations and is considered to be less risky than IBCA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PCRBIBCADifference

Volatility (1M)

Calculated over the trailing 1-month period

1.32%

1.62%

-0.30%

Volatility (6M)

Calculated over the trailing 6-month period

2.66%

3.62%

-0.96%

Volatility (1Y)

Calculated over the trailing 1-year period

3.77%

4.96%

-1.19%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

5.63%

5.76%

-0.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

5.63%

5.76%

-0.13%

PCRB vs. IBCA - Expense Ratio Comparison

PCRB has a 0.35% expense ratio, which is higher than IBCA's 0.10% expense ratio.


Dividends

PCRB vs. IBCA - Dividend Comparison

PCRB's dividend yield for the trailing twelve months is around 9.79%, more than IBCA's 4.67% yield.


PositionTTM202520242023
IBCA
iShares iBonds Dec 2035 Term Corporate ETF
4.67%3.19%0.00%0.00%
PCRB
Putnam ESG Core Bond ETF -
9.79%4.30%4.38%3.65%

Frequently Asked Questions


PCRB and IBCA have a correlation of 0.90, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBCA has higher volatility (1.62%) compared to PCRB (1.32%). In terms of maximum drawdown, PCRB dropped -7.20% vs IBCA's -3.48%.

On 1-year performance, IBCA leads with 6.55% vs 4.53% for PCRB. On fees, IBCA is cheaper at 0.10% per year. On volatility, PCRB has been the lower-risk option at 1.32%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, IBCA has performed better with a 6.55% return vs 4.53%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IBCA is cheaper with a 0.10% expense ratio, compared with 0.35% for PCRB.

PCRB has the higher dividend yield at 9.79%, compared with 4.67% for IBCA.

They also come from different issuers: Putnam and iShares. Their fees differ too: 0.35% for PCRB and 0.10% for IBCA.

IBCA currently has the higher Sharpe Ratio (1.33 vs 1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PCRB and IBCA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer